403 related articles for article (PubMed ID: 17876564)
1. IDO-expressing regulatory dendritic cells in cancer and chronic infection.
Popov A; Schultze JL
J Mol Med (Berl); 2008 Feb; 86(2):145-60. PubMed ID: 17876564
[TBL] [Abstract][Full Text] [Related]
2. Induction of regulatory T Cells by dendritic cells through indoleamine 2,3-dioxygenase: a potent mechanism of acquired peripheral tolerance.
Trabanelli S; Ocadlikova D; Evangelisti C; Parisi S; Curti A
Curr Med Chem; 2011; 18(15):2234-9. PubMed ID: 21517756
[TBL] [Abstract][Full Text] [Related]
3. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.
Katz JB; Muller AJ; Prendergast GC
Immunol Rev; 2008 Apr; 222():206-21. PubMed ID: 18364004
[TBL] [Abstract][Full Text] [Related]
4. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition.
von Bergwelt-Baildon MS; Popov A; Saric T; Chemnitz J; Classen S; Stoffel MS; Fiore F; Roth U; Beyer M; Debey S; Wickenhauser C; Hanisch FG; Schultze JL
Blood; 2006 Jul; 108(1):228-37. PubMed ID: 16522817
[TBL] [Abstract][Full Text] [Related]
5. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
Zamanakou M; Germenis AE; Karanikas V
Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
[TBL] [Abstract][Full Text] [Related]
6. Tolerogenic Phenotype of IFN-γ-Induced IDO+ Dendritic Cells Is Maintained via an Autocrine IDO-Kynurenine/AhR-IDO Loop.
Li Q; Harden JL; Anderson CD; Egilmez NK
J Immunol; 2016 Aug; 197(3):962-70. PubMed ID: 27316681
[TBL] [Abstract][Full Text] [Related]
7. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-dioxygenase: from catalyst to signaling function.
Fallarino F; Grohmann U; Puccetti P
Eur J Immunol; 2012 Aug; 42(8):1932-7. PubMed ID: 22865044
[TBL] [Abstract][Full Text] [Related]
9. Molecules in focus: indoleamine 2,3-dioxygenase.
King NJ; Thomas SR
Int J Biochem Cell Biol; 2007; 39(12):2167-72. PubMed ID: 17320464
[TBL] [Abstract][Full Text] [Related]
10. The immunoregulatory role of IDO-producing human dendritic cells revisited.
Terness P; Chuang JJ; Opelz G
Trends Immunol; 2006 Feb; 27(2):68-73. PubMed ID: 16406698
[TBL] [Abstract][Full Text] [Related]
11. Haemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase via type I interferons and tumor necrosis factor alpha in human dendritic cells.
Li W; Katz BP; Spinola SM
Infect Immun; 2011 Aug; 79(8):3338-47. PubMed ID: 21576329
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.
Harden JL; Egilmez NK
Immunol Invest; 2012; 41(6-7):738-64. PubMed ID: 23017144
[TBL] [Abstract][Full Text] [Related]
13. Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation.
Brandacher G; Margreiter R; Fuchs D
Curr Drug Metab; 2007 Apr; 8(3):273-82. PubMed ID: 17430115
[TBL] [Abstract][Full Text] [Related]
14. Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells.
Jeong YI; Kim SW; Jung ID; Lee JS; Chang JH; Lee CM; Chun SH; Yoon MS; Kim GT; Ryu SW; Kim JS; Shin YK; Lee WS; Shin HK; Lee JD; Park YM
J Biol Chem; 2009 Feb; 284(6):3700-8. PubMed ID: 19075017
[TBL] [Abstract][Full Text] [Related]
15. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3+ regulatory T cells.
Xie FT; Cao JS; Zhao J; Yu Y; Qi F; Dai XC
Transpl Immunol; 2015 Oct; 33(2):69-77. PubMed ID: 26002283
[TBL] [Abstract][Full Text] [Related]
16. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
[TBL] [Abstract][Full Text] [Related]
17. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.
Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R
Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase in transplantation.
Mulley WR; Nikolic-Paterson DJ
Nephrology (Carlton); 2008 Jun; 13(3):204-11. PubMed ID: 18221253
[TBL] [Abstract][Full Text] [Related]
19. Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.
Muller AJ; Sharma MD; Chandler PR; Duhadaway JB; Everhart ME; Johnson BA; Kahler DJ; Pihkala J; Soler AP; Munn DH; Prendergast GC; Mellor AL
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17073-8. PubMed ID: 18952840
[TBL] [Abstract][Full Text] [Related]
20. A potential role for indoleamine 2,3-dioxygenase (IDO) in Rhodococcus equi infection.
Heller MC; Drew CP; Jackson KA; Griffey S; Watson JL
Vet Immunol Immunopathol; 2010 Dec; 138(3):174-82. PubMed ID: 20739070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]